Shanghai Pharmaceutical (601607.SH) subsidiary plans to list and sell 41% equity of Shangyao Yiyao Pharmaceutical (Shanghai) Co., Ltd.

China Fortune Financial News APP News, Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary, Shanghai Pharmaceuticals Group Co., Ltd., intends to transfer its 41% stake in its controlled subsidiary Shanghai Yiyao Pharmaceutical Co., Ltd. through public listing on the property rights exchange. The listing transfer price is set at 330 million yuan (the final price shall not be lower than the valuation value filed by the state-owned assets assessment), and the final transfer price shall be based on the results of the public listing transaction. After the completion of this transaction, Shanghai Pharmaceuticals will hold 10% of the target company through Shanghai Pharmaceuticals Group, and will no longer consolidate the target company.